Screening for proteinuria in US adults: a cost-effectiveness analysis.
about
Screening with urinary dipsticks for reducing morbidity and mortalityMeasuring the value of public health systems: the disconnect between health economists and public health practitionersTranslational research in nephrology: chronic kidney disease prevention and public healthMethods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic ReviewReducing the costs of chronic kidney disease while delivering quality health care: a call to action.The costs and benefits of automatic estimated glomerular filtration rate reporting.Age-related associations of hypertension and diabetes mellitus with chronic kidney disease.High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo.Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veteransStrategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney diseasePrevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes.Chronic kidney disease and end-stage renal disease-a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe'.Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES).Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States.Significance of past history of renal failure for the detection of high-risk individuals for cardiovascular and end-stage renal disease: analysis of data from a nationwide health checkup.Elevated body mass index as a risk factor for chronic kidney disease: current perspectives.Population based screening for chronic kidney disease: cost effectiveness study.Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.Routine screening for CKD should be done in asymptomatic adults... selectivelyPrevalence of chronic kidney disease across levels of glycemia among adults in Pudong New Area, Shanghai, China.Association between family members of dialysis patients and chronic kidney disease: a multicenter study in China.An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.Global proteinuria guidelines: are we nearly there yet?Chronic kidney disease: a public health problem that needs a public health action planCost-effectiveness analysis of a randomized trial comparing care models for chronic kidney diseasePrevalence of chronic kidney disease and its association with metabolic diseases: a cross-sectional survey in Zhejiang province, Eastern China.Development and validation of a self-assessment tool for albuminuria: results from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey.Dipstick proteinuria as a screening strategy to identify rapid renal decline.Prevalence of chronic kidney disease in India - Where are we heading?Risk Prediction for Early CKD in Type 2 Diabetes.Albuminuria and its associated biomedical factors among indigenous adults in Far North Queensland: a 7-year follow up study.Cost-effectiveness of chronic kidney disease mass screening test in Japan.Screening for CKD with eGFR: doubts and dangers.The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.Predictors of diabetic end-stage renal disease in Japan.The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers.The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.Validation of an Albuminuria Self-assessment Tool in the Multi-Ethnic Study of AtherosclerosisCost-effectiveness of screening for microalbuminuria among African Americans.
P2860
Q24186492-7B0B1F17-B472-4F91-87CE-968BFF0D9482Q24657827-ACFF93CF-58D6-483A-9F28-8FED8F1E4AFCQ26776395-AE1FAD60-B7D1-4820-AB26-9DF799E9E238Q26783181-E3F98440-79B0-4D4F-B4B8-DA99168F163CQ30234324-6BF6DD9F-7CB3-4B04-A211-027C0BCFDEBBQ30437160-F2A8582C-4BF6-4CDF-A780-4B48C6C48C24Q33475999-E9BBDFBE-6881-407F-A84B-7A47FAAA89F2Q33484989-7032CF5F-5940-4796-AF62-2FD65C73869DQ33556410-B134F819-91A7-4944-8903-541282E71E1BQ33576711-4AED5B0C-CCDA-4ADD-8249-E413C43B5207Q33770056-4C1168F2-3288-4F08-AD2C-923864ABA540Q33816875-437F5080-C701-4D9A-B8D3-2038BB9E185DQ33859246-91BEB1F2-7654-4E7A-99C0-5B9A03700B60Q33893332-A11FEF91-9E45-4D43-82F5-326AE04CCA16Q33983591-60DA876E-4601-44D9-89AB-61A6470F83B9Q34005600-0196FA29-2161-442D-A87F-907E235A5D94Q34286311-6B2B93E7-09D2-4B35-BD93-EC282E843A4EQ34429278-00BD0E9F-C5DC-4CA5-98A8-3802A42B776FQ34455134-63D76EAD-F66C-4CAA-9830-1BA9AC583C89Q34478646-D23DAE45-F114-4DF7-B25E-8C2675CF5BB9Q34554136-BED1108A-E258-4671-AD27-8EFD056E12DAQ34995601-7753F32C-196E-44FA-BCD3-A47404DE73E9Q34999959-1E385614-228A-4B0E-B644-3F7C945790C3Q35024506-4FFE9BE5-9E1D-42DB-B63E-6223DD4F74C6Q35030546-32693C47-9807-4FA8-AD48-4EBE64BA2A26Q35100226-C1C43041-B1FD-4113-AD0D-0B993E88C557Q35129851-BFBF1AA2-BE20-4393-9980-4528F16C8BBBQ35148118-510DE96F-64B5-4F10-BD3A-E9EC82B3F490Q35210221-DCAF71CF-EE1D-45FC-9E35-2A33CBA15ECAQ35658756-B1ABB769-201D-48CA-8EA3-28C60A78C758Q35691583-039C0822-3080-4A59-A360-73E7186388BFQ35864610-F6D5DF78-04A6-447A-A953-C23DDEB43D04Q35895018-A5ADEE28-2273-4C2A-A68D-3C54BD3C190AQ36063274-912958A3-5A02-4B7C-8FD4-5A415137CE7AQ36073903-FA06AC1F-D21B-4ACF-B357-9E5E5CA212F6Q36262390-59BC6A6A-3182-401A-B189-11C2EC1B0E0FQ36295307-D46A401B-2650-40BD-BC9A-2397E6FDB7B4Q36306581-375197EE-0E56-4792-857B-38B3CF47FD0BQ36351454-EF36F3EB-4F46-4936-BDAB-B422401600B4Q36426101-37E4B9E7-B458-48B2-A803-0CC51A60BDD5
P2860
Screening for proteinuria in US adults: a cost-effectiveness analysis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Screening for proteinuria in US adults: a cost-effectiveness analysis.
@en
Screening for proteinuria in US adults: a cost-effectiveness analysis.
@nl
type
label
Screening for proteinuria in US adults: a cost-effectiveness analysis.
@en
Screening for proteinuria in US adults: a cost-effectiveness analysis.
@nl
prefLabel
Screening for proteinuria in US adults: a cost-effectiveness analysis.
@en
Screening for proteinuria in US adults: a cost-effectiveness analysis.
@nl
P2093
P356
P1476
Screening for proteinuria in US adults: a cost-effectiveness analysis.
@en
P2093
Frederick L Brancati
L Ebony Boulware
Michelle E Tarver-Carr
Neil R Powe
P304
P356
10.1001/JAMA.290.23.3101
P407
P577
2003-12-01T00:00:00Z